Since HIF activation may induce the expression of a wide range of genes, some potential off-target effects of PHD inhibitors, such as reducing complement C1q levels and progression in polycystic kidney disease, should also be taken into consideration. This evidence concerns the gene PDC and polycystic kidney disease.